Treating the Penicillin-allergic Patient

Publication
Article
Internal Medicine World ReportFebruary 2015

A frequent challenge when prescribing antibiotics is what to prescribe for the patient who states they are allergic to penicillin. This is particularly true when prescribing cephalosporins. The frequently quoted rate of cross-sensitivity between penicillin and cephalosporins is between 5 and 10 percent.

A frequent challenge when prescribing antibiotics is what to prescribe for the patient who states they are allergic to penicillin. This is particularly true when prescribing cephalosporins. The frequently quoted rate of cross-sensitivity between penicillin and cephalosporins is between 5 and 10%.

However, recent studies show that the rate is actually less than 1%. When prescribing cephalosporins for penicillin-allergic patients, clinicians should realize that any possible reaction is not due to a β-lactam ring but due to the R group side chain. Drugs of similar side chains to penicillin include cefotaxime, cefaclor, ceftriaxone, cefpodoxime, cefepime, and cephaloridine.

When assessing for cross‐reactions it is important to know what type of reaction the patient had to penicillin. The only significant reaction to note is a type I anaphylaxis reaction. In patients with documented anaphylaxis to penicillin avoid use of cephalosporins with similar R group side chains.

Both second- and third-generation cephalosporins are highly unlikely to demonstrate cross‐reactivity to penicillin based on their structures compared to early-generation cephalosporins.

Recent Videos
Developing Risk Assessment Tools for Viruses in School
What Do Patients Need to Learn About their Hypersensitivity Pneumonitis?
Allergies and Asthma During the School Year, with S. Christy Sadeameli, MD, and Juanita Mora, MD
Impact of the Nasal Epinephrine Spray for Patients with Severe Allergies, with Edwin H. Kim, MD
Getting Black Men Involved in Their Health Care, Clinical Research
Patient Involvement in Advanced HF Treatment, with Ashley Malliett, DMSc, MPAS, PA-C
Aaron Henry, PA-C, MSHS: Regaining Black Male Patient Trust in the Doctor's Office
What Should the American Academy of Physician Associates Focus on in 2025?
Danielle O'Laughlin, PA-C, MS: Navigating Long-Term Risks, Family Planning in PCOS
© 2024 MJH Life Sciences

All rights reserved.